Effect of dopamine on esophageal motor function

Area of Science:

• Gastroenterology
• Pharmacology
• Physiology

Background:

• Dopamine's role in esophageal motor function is not fully understood.
• Investigating dopamine's specific receptor interactions in the esophagus is crucial.

Purpose of the Study:

• To elucidate the effects of intravenous dopamine on esophageal motility.
• To identify the receptor pathways mediating dopamine's actions on the esophagus.

Main Methods:

• Dopamine was administered intravenously to opossums in a dose-dependent manner.
• The effects on lower esophageal sphincter pressure and esophageal body contractions were measured.
• Pharmacological agents (atropine, phentolamine, propranolol, vagotomy, haloperidol, bulbocapnine) were used to probe receptor involvement.

Main Results:

• Dopamine caused a dose-dependent decrease in lower esophageal sphincter pressure and increased esophageal body contractions.
• The effects plateaued at approximately 6 mug/kg, with significant reductions in pressure and increased contractions observed.
• Haloperidol and bulbocapnine antagonized dopamine's effects, while other tested agents did not.
• Haloperidol administration increased esophageal contraction amplitude in response to stimulation.

Conclusions:

• Intravenous dopamine significantly alters esophageal motor function, affecting both the lower esophageal sphincter and the esophageal body.
• Dopamine's effects are mediated via specific dopamine receptors, independent of vagal, cholinergic, or adrenergic pathways.
• Inhibitory dopamine receptors likely play a physiological role in regulating esophageal contraction amplitude.